Colgate-Palmolive (NYSE:CL) Position Reduced by D.A. Davidson & CO.

D.A. Davidson & CO. trimmed its stake in Colgate-Palmolive (NYSE:CL) by 1.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,205 shares of the company’s stock after selling 1,971 shares during the quarter. D.A. Davidson & CO.’s holdings in Colgate-Palmolive were worth $9,473,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. Chicago Partners Investment Group LLC lifted its position in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after purchasing an additional 943 shares in the last quarter. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $1,315,000. Gordian Advisors LLC acquired a new position in Colgate-Palmolive in the third quarter worth approximately $602,000. Carrera Capital Advisors increased its holdings in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $4,066,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays dropped their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Stock Up 0.4 %

CL opened at $86.41 on Wednesday. The stock has a market capitalization of $70.60 billion, a price-to-earnings ratio of 24.55, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $83.70 and a 1-year high of $109.30. The business has a 50 day moving average of $89.39 and a 200-day moving average of $96.22. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.